Prepare for your visit

Katayoun Lotfi

Endocrinology, Diabetes & Metabolism · Mountain View, CA · NPI 1619288685

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$700.42

in general payments reported to CMS, 2019-2025 · $217 in 2025

The $217 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).

Who reported paying

General payments only, top 2 by amount.

Novo Nordisk INC $670.19
Rhythm Pharmaceuticals, INC. $30.23

Questions you might ask

I saw Katayoun Lotfi listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/73308/katayoun-lotfi